EUVIMEDEUVIMED entdecken
Crossref

Ketamine Use in Critically Ill Patients: Insights into Depressive Symptoms and Hemodynamic Changes

Vrutti Patel iD, Saurabh Sujanyal iD, Lekhya Raavi, Sophia G Blumenfeld, Faiz Saleem iD, Said Bateh, Abby Hanson iD, Anek Jena iD, Shahin Isha iD, Katie L Kunze, Patrick W Johnson, Katheleen A Rottman Pietrzak und 8 weitere

Journal of Intensive Care Medicine · 2026-12 · 41 (12) · 1287-1296

DOI: 10.1177/08850666261438474 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Intensive Care Medicine, online erschienen am 16.04.2026. Verfasst von Vrutti Patel und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, Mayo Clinic, Florida, Jacksonville, FL, USA. Hauptthemen laut MEDLINE: Ketamine, Critical Illness, Hemodynamics, Depression. Die Arbeit nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ketamine has demonstrated efficacy in treatment-resistant depression, primarily in psychiatric or outpatient populations. Its use in ICU patients remains underexplored, with limited data beyond case reports and small series. This study evaluated the association between subanesthetic ketamine infusions and improvement in depressive symptoms and hemodynamic changes in ICU patients.

Methods

We conducted a retrospective study of adults admitted to the ICU who received IV ketamine (0.3-0.75 mg/kg over 40 min on three consecutive days) for depressive symptoms. Changes in depressive symptoms were assessed using routine clinical documentation by physicians, nurses, and occupational and physical therapists. Hemodynamic parameters (blood pressure and heart rate) were recorded before and up to 120 min after infusion. The primary outcome was to evaluate depressive symptoms while the secondary outcome was to assess hemodynamic changes post transfusion.

Results

Thirty-four patients met criteria, including 18 solid organ transplant recipients. Median age was 59 years; 61.8% were male. Ketamine was associated with improvement in apparent sadness (90.0% vs 52.2%, P < .05) and reported sadness (95.0% vs 59.1%, P < .05). In transplant recipients, improvement in apparent sadness remained significant (80.0% vs 41.7%, P < .05). Hemodynamic parameters remained stable; heart rate increased transiently at 15-30 min post-infusion, returning to baseline by 60-90 min. Adverse effects observed were anxiety (12.5%), restlessness and/or agitation (10.4%), and dissociation (8.16%).

Conclusion

Subanesthetic ketamine improved specific depressive symptoms in critically ill ICU patients without significant hemodynamic instability. These findings support its potential as a rapid-acting antidepressant in the ICU, warranting further prospective trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KetamineCritical IllnessHemodynamicsDepressionAntidepressive AgentsHumansMaleFemaleMiddle AgedRetrospective StudiesIntensive Care UnitsAgedAdultHeart RateTreatment OutcomeInfusions, Intravenous

Stichwörter der Autor:innen

depressionhemodynamic stabilityintensive care unitketamine

Substanzen

KetamineAntidepressive Agents

Autor:innen und Institutionen

  • Department of Critical Care Medicine, Mayo Clinic, Florida, Jacksonville, FL, USA.
  • Department of Quantitative Health Sciences, Mayo Clinic, Florida, Jacksonville, FL, USA.
  • Department of Anesthesiology, Mayo Clinic, Florida, Jacksonville, FL, USA.
  • Department of Internal Medicine, Ascension Saint Joseph Hospital, Chicago, Chicago, IL, USA.
  • Department of Quantitative Health Sciences, Mayo Clinic, Arizona, Phoenix, AZ, USA.
  • Department of Intensive Care Unit, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.

ORCID-Profile: Vrutti Patel, Saurabh Sujanyal, Faiz Saleem, Abby Hanson, Anek Jena, Shahin Isha, Michelle M Ojard, Ivan A Huespe, Pablo Moreno Franco, Mohit Chauhan, Devang Sanghavi

Zitieren

APA

Patel, V., Sujanyal, S., Raavi, L., Blumenfeld, S. G., Saleem, F., Bateh, S., Hanson, A., Jena, A., Isha, S., Kunze, K. L., Johnson, P. W., Rottman Pietrzak, K. A., Ojard, M. M., Huespe, I. A., Shah, S. Z., Franco, P. M., Edwards, M. A., Chauhan, M., Sanghavi, D., & Anna, S. (2026). Ketamine Use in Critically Ill Patients: Insights into Depressive Symptoms and Hemodynamic Changes. Journal of Intensive Care Medicine, 41(12), 1287-1296. https://doi.org/10.1177/08850666261438474

Vancouver

Patel V, Sujanyal S, Raavi L, Blumenfeld SG, Saleem F, Bateh S, et al. Ketamine Use in Critically Ill Patients: Insights into Depressive Symptoms and Hemodynamic Changes. Journal of Intensive Care Medicine. 2026;41(12):1287-1296. doi:10.1177/08850666261438474

BibTeX
@article{Patel2026,
  author = {Patel, Vrutti and Sujanyal, Saurabh and Raavi, Lekhya and Blumenfeld, Sophia G and Saleem, Faiz and Bateh, Said and Hanson, Abby and Jena, Anek and Isha, Shahin and Kunze, Katie L and Johnson, Patrick W and Rottman Pietrzak, Katheleen A and Ojard, Michelle M and Huespe, Ivan A and Shah, Sadia Z and Franco, Pablo Moreno and Edwards, Michael A and Chauhan, Mohit and Sanghavi, Devang and Anna, Shapiro},
  title = {Ketamine Use in Critically Ill Patients: Insights into Depressive Symptoms and Hemodynamic Changes},
  journal = {Journal of Intensive Care Medicine},
  year = {2026},
  volume = {41},
  number = {12},
  pages = {1287--1296},
  doi = {10.1177/08850666261438474}
}
Kostenlos starten →